A kind of urea-derived bladder cancer cell culture medium and in vitro culture method of urea-derived bladder cancer cells

A bladder cancer cell culture technology in vitro, which is applied in the field of urinary bladder cancer cell culture medium and urine-derived bladder cancer cell culture in vitro, and can solve the problems of cumbersome operation of bladder cancer cells, unsustainable subculture, easy failure cells, etc. problem, to achieve the effect of solving culture failure, increasing cell number and activity, and eliminating cell contamination

Active Publication Date: 2021-12-10
深圳涌泰生物科技有限公司
View PDF5 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0010] In order to solve the problems of cumbersome operation, easy failure or cell contamination, and unsustainable subculture in the prior art for culturing urogenous bladder cancer cells, the present invention provides a urogenous bladder cancer cell culture medium BLM and based on sample collection liquid (sample The collection solution is PBS buffer containing 2% penicillin / streptomycin, 100 μg / mL nystatin), and PBS buffer to separate urinary bladder cancer cells, and use BLM medium to provide a simple, stable and effective The method for the primary and subculture of urogenous bladder cancer cells

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • A kind of urea-derived bladder cancer cell culture medium and in vitro culture method of urea-derived bladder cancer cells
  • A kind of urea-derived bladder cancer cell culture medium and in vitro culture method of urea-derived bladder cancer cells
  • A kind of urea-derived bladder cancer cell culture medium and in vitro culture method of urea-derived bladder cancer cells

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0054] [Example 1] Urine sampling:

[0055] (1) Sampling objects: male patients with bladder cancer;

[0056] (2) Sampling requirements: Before urine collection, strenuous exercise such as running and climbing stairs should be avoided, and contamination by various substances such as semen, prostatic fluid, and feces should be avoided (urine samples should be sampled before surgery for bladder cancer patients);

[0057] (3) Preparation before the experiment: add 20mL of sample collection solution into a 50mL sterile centrifuge tube to collect urine;

[0058] (4) Clean the urethral area with tincture of benzalkonium bromide, discard the first section of urine, take the interrupted urine, and collect it into the above-mentioned centrifuge tube, each tube can collect 20mL of urine, each patient collects 3 tubes, refrigerated transported to the cell culture room.

[0059] According to the above method (such as figure 1 ) to collect urine samples for primary and subculture of uri...

Embodiment 2

[0060] [Example 2] Primary culture of urethrogenic bladder cancer cells, changing medium:

[0061] (1) The sample was centrifuged at 1500rmp for 8min, and the supernatant was discarded by centrifugation;

[0062] (2) Add 10 mL of PBS buffer solution to wash twice, centrifuge at 1000 rpm for 5 min, and discard the supernatant;

[0063] (3) Resuspend the pellet with 1mL of BLM medium, and inoculate it in a T25 culture bottle, supplement the medium to 7mL in each bottle, and add cells that lose their proliferative ability but still maintain metabolic activity after radiation irradiation or drug mitogenin C treatment. Mouse fibroblasts are about 2 x 10 6 cells / mL co-culture, put in 37 ℃, 5% CO 2 After culturing in the incubator for 36 hours, observe the growth status of the cells under a microscope. The mouse fibroblasts are the mouse fibroblasts MFC / HL-041 in the application number: 201810335862.8 Chinese patent application, which are preserved in the China Center for Type Cult...

Embodiment 3

[0067] [Example 3] Subculture of urogenous bladder cancer cells:

[0068] (1) When the fusion degree of the above-mentioned urinary bladder cancer cells reaches more than 85%, it can be digested and passaged, and the old culture medium is discarded;

[0069] (2) Rinse the cells with PBS buffer to remove cell secretions that hinder trypsin digestion, wash twice, and the operation steps must be gentle;

[0070] (3) After adding 1 mL of EDTA with a concentration of 0.02%, shake it gently to make it fully contact with the cells on the culture flask, and tap the outer wall of the culture flask after 20-30 seconds to make the mouse fibroblasts fall off the wall of the culture flask. After the mouse fibroblasts were all detached from the bottle wall under the microscope, EDTA was quickly removed, and the bladder cancer cells were washed with PBS for 3 times;

[0071] (4) Add 1mL 0.05% trypsin-EDTA, incubate at 37°C for 4min to digest, shake the cell culture flask lightly to make the...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a urea-derived bladder cancer cell culture medium and an in vitro culture method of the urea-derived bladder cancer cells. The invention provides a urine-derived bladder cancer cell based on the separation of sample collection liquid and PBS buffer, and adopts BLM medium to co-culture with inactivated mouse fibroblasts to provide a simple, stable and effective treatment for urinary bladder cancer cells. A method for primary and subcultured primary bladder cancer cells. This method amplifies urinary bladder cancer cells and allows them to grow stably in a short period of time. The cells can accurately reflect the physiological conditions of patients, and can successfully establish the early screening of bladder cancer for urinary bladder cancer cells derived from cancer patients, A new model for bladder cancer recurrence monitoring, bladder cancer curative effect monitoring, and drug sensitivity test-guided medication can be used for dynamic monitoring of urine cells in cancer patients, drug sensitivity test-guided medication, and research and development of new anticancer drugs.

Description

technical field [0001] The invention belongs to the field of cell biology, and relates to a culture medium of urinary bladder cancer cells and an in vitro culture method of urinary bladder cancer cells. Background technique [0002] Epidemiological surveys have found that bladder cancer is the most common malignant tumor in the urinary system, and its incidence rate ranks ninth among malignant tumors in the world. The incidence rate of men is 3 to 4 times that of women, and its incidence increases with age. trend. Among them, 90% of bladder cancer belongs to bladder urothelial carcinoma, and the recurrence rate is as high as 30-80% within 5 years after tumor resection. Therefore, early screening and recurrence detection of tumors are very important for the treatment of bladder cancer and to reduce the recurrence rate after surgery. [0003] Cystoscopy and biopsy are the most reliable methods for diagnosing bladder cancer. Patients undergo routine cystoscopy to observe the ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): C12N5/09C12N5/071
CPCC12N5/0693C12N2501/15C12N2501/33C12N2501/39C12N2501/81C12N2502/1323C12N2501/01C12N2501/11
Inventor李晖叶立娜陈雨杨华东蔡铠红张康魏高斌曾志宏
Owner深圳涌泰生物科技有限公司